Glazer Capital’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
Glazer Capital's CPRX Position: Q2 2026 in Review
Glazer Capital opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 3,602,865 shares worth $113M. The stake represents 2.79% of the portfolio and ranks #6 among its holdings.
400 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.
- Glazer Capital held 3,602,865 shares of Catalyst Pharmaceutical worth $113M as of Q2 2026.
- Catalyst Pharmaceutical was a new Glazer Capital position in Q2 2026.
- Catalyst Pharmaceutical made up 2.79% of Glazer Capital's portfolio in Q2 2026, its #6 holding.
- 400 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.
Based on Glazer Capital's 13F filing for Q2 2026, filed 17 Aug 2026.